Home NDC 55529-021 NDC 55529-021 - Norocillin This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
Product NDC 55529-021
Package NDCs from labels 55529-021-02, 55529-021-04, 55529-021-05
Manufacturer Norbrook Laboratories Limited
Effective date 2025-01-27
Current FDA listing Not matched in FDA.report NDC product tables DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 55529-021-02 Norocillin 100 mL in 1 VIAL, GLASS INJECTION, SUSPENSION 100 6 55529-021-04 Norocillin 250 mL in 1 VIAL, GLASS INJECTION, SUSPENSION 250 6 55529-021-05 Norocillin 500 mL in 1 VIAL, GLASS INJECTION, SUSPENSION 500 6
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 55529-021 NOROCILLIN (PENICILLIN G PROCAINE) INJECTION, SUSPENSION [NORBROOK LABORATORIES LIMITED] 6 3 package rows 20250129_0116d56d-53f8-429e-b0fc-5319af7fe903.zip
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded penicillin G procaine ACTIVE INGREDIENT 17R794ESYN NOROCILLIN (PENICILLIN G PROCAINE) INJECTION, SUSPENSION [NORBROOK LABORATORIES LIMITED] 2 penicillin G procaine ACTIVE MOIETY 17R794ESYN NOROCILLIN (PENICILLIN G PROCAINE) INJECTION, SUSPENSION [NORBROOK LABORATORIES LIMITED] 2 carboxymethylcellulose sodium INACTIVE INGREDIENT K679OBS311 NOROCILLIN (PENICILLIN G PROCAINE) INJECTION, SUSPENSION [NORBROOK LABORATORIES LIMITED] 2 lecithin, soybean INACTIVE INGREDIENT 1DI56QDM62 NOROCILLIN (PENICILLIN G PROCAINE) INJECTION, SUSPENSION [NORBROOK LABORATORIES LIMITED] 2 methylparaben INACTIVE INGREDIENT A2I8C7HI9T NOROCILLIN (PENICILLIN G PROCAINE) INJECTION, SUSPENSION [NORBROOK LABORATORIES LIMITED] 2 penicillin G potassium INACTIVE INGREDIENT VL775ZTH4C NOROCILLIN (PENICILLIN G PROCAINE) INJECTION, SUSPENSION [NORBROOK LABORATORIES LIMITED] 2 polysorbate 80 INACTIVE INGREDIENT 6OZP39ZG8H NOROCILLIN (PENICILLIN G PROCAINE) INJECTION, SUSPENSION [NORBROOK LABORATORIES LIMITED] 2 potassium phosphate, dibasic INACTIVE INGREDIENT CI71S98N1Z NOROCILLIN (PENICILLIN G PROCAINE) INJECTION, SUSPENSION [NORBROOK LABORATORIES LIMITED] 2 potassium phosphate, monobasic INACTIVE INGREDIENT 4J9FJ0HL51 NOROCILLIN (PENICILLIN G PROCAINE) INJECTION, SUSPENSION [NORBROOK LABORATORIES LIMITED] 2 procaine hydrochloride INACTIVE INGREDIENT 95URV01IDQ NOROCILLIN (PENICILLIN G PROCAINE) INJECTION, SUSPENSION [NORBROOK LABORATORIES LIMITED] 2 sodium formaldehyde sulfoxylate INACTIVE INGREDIENT X4ZGP7K714 NOROCILLIN (PENICILLIN G PROCAINE) INJECTION, SUSPENSION [NORBROOK LABORATORIES LIMITED] 2 water INACTIVE INGREDIENT 059QF0KO0R NOROCILLIN (PENICILLIN G PROCAINE) INJECTION, SUSPENSION [NORBROOK LABORATORIES LIMITED] 2
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 28 of 28 · 541 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join TIS-U-SOL SODIUM CHLORIDE, POTASSIUM CHLORIDE, MAGNESIUM SULFATE, SODIUM PHOSPHATE, AND POTASSIUM PHOSPHATE Baxter Healthcare Corporation 9da4121f-d62d-4da4-8dfb-0494da16015f 2014-02-21 Exact identifier unii: 4J9FJ0HL51
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.